Travelers Can Enjoy National Wellness Month At These Holistic Spas
Celebrated every August, National Wellness Month serves as a time to highlight the importance of overall well-being by encouraging individuals to prioritize their physical, mental and emotional health, and destination spas are ready to welcome travelers who seek rejuvenation and relaxation during their getaways.
It's a month that raises awareness about the value of self-care, stress management and healthy routines, aiming to inspire people to adopt practices that improve their overall wellness.
Three key components of the month include:
* Promoting the adoption of habits that support physical and mental health, such as balanced diets, regular exercise and sufficient sleep.
* Respecting the interconnectedness of physical, mental and emotional well-being, by way of a balanced approach to health.
* Highlighting the importance of making time for activities that promote well-being, such as relaxation and hobbies.
According to several recent surveys, one-fourth of travelers plan to take a health and wellness-focused trip in the next year, a striking 51% increase from the previous year. Many of these travelers will head to hotels and resorts that feature luxurious spas and soothing treatments.
Omni Hotels & Resorts offers a variety of relaxing spa treatments. Omni Hotels & Resorts
Omni Hotels & Resorts is tapping into the moment with a spa collection designed to meet guests where they are, whether that's burnout, bridal season or a solo reset. The Spa at La Costa (Carlsbad, CA): Following a 2024 renovation, this 43,000-square-foot spa fuses time-honored wellness traditions with cutting-edge therapies like cryotherapy and sound baths; this summer's highlights include exclusive Secret Garden Spa Parties with live music and tranquil sound baths, plus innovative Spa Summer Camps designed for parents and teens to bond through curated treatments and activities. The Spa at Omni Grove Park Inn & Spa (Asheville, NC): Set deep within the Blue Ridge Mountains, this subterranean spa carved from natural rock offers a transformative retreat built around the elements of Fire, Rock, Water and Light with this summer's Spa After Hours giving private groups exclusive access to pools and amenities in a uniquely serene mountain setting.
Treatments are designed to relax both the mind and body. The Benjamin Royal Sonesta Hotel The Benjamin Royal Sonesta Hotel, New York City
The Benjamin Royal Sonesta Hotel, a luxury boutique landmark hotel in New York City, has debuted the Royal Reflection Wellness Spa, offering relaxation, beauty and holistic healing treatments in a serene environment with expert therapists. Designed by the DLR Group, the initial phase of The Benjamin's reimagination was unveiled in September 2024. The transformation reveals a present-day interpretation of the urban oasis, combining design elements of classic elegance with modern flair to create an elegant ambiance reminiscent of a members-only club. The Royal Reflection Wellness Spa offers guests a variety of treatments designed to relax both the mind and body, leaving spa-goers feeling refreshed and revitalized. From invigorating body treatments to renewing skincare and beauty rituals, treatment options include massages (deep tissue, lymphatic release, Swedish), facials, acupuncture, body scrubs, eyelash extensions, and more. Expert therapists blend time-honored traditional techniques and contemporary practices, tailored to each guest. Guests also have the option of in-room massages, ensuring the ultimate relaxation in the comfort of their own spacious suite.
Serenbe offers guests a restorative wellness experience. Tomas Espinoza Photography Serenbe, Atlanta, Georgia
Just 25 minutes from Atlanta's airport, Serenbe is part wellness retreat, part residential community. With 70% of Serenbe preserved as green space, the destination offers guests a restorative wellness experience: forest bathing, organic farm tours, guided labyrinth meditations, award-winning spa treatments and hyper-local farm-to-table meals. It's no surprise the Global Wellness Institute named 'analog travel' as one of the year's top trends, and Serenbe goes all in. No noise, no rush, just nature, fresh food and meaningful connection. Guests who want to connect with nature can stay at The Inn at Serenbe or one of the cottages within the community to unplug, stroll the countryside by horseback with the Serenbe Trail Riding, cool off at the lake, tour one of the state's first certified organic farms and visit the adjacent farmers market, try out forest bathing and hike through 26 miles of preserved wooded trails that connect the community.
Treatments include a Summer Glow-Up Facial. Carley Rudd Photography Mountain View Grand Resort & Spa, Whitefield, New Hampshire
Immersed in natural splendor with prime access to exhilarating outdoor adventure, delicious dining and decadent spa treatments, Mountain View Grand Resort & Spa is a timeless 1,700-acre escape. Classes include Sunrise Yoga on the Lawn on Saturdays; Private Stress-Relief & Mindfulness Meditation Sessions; Beyond Relief Yoga & Custom Private Yoga Classes on Tuesdays & Saturdays; Wellness Packages; The Glow-Up; 50-Minute Summer Glow-Up Facial; 80-Minute Revitalizing Scalp Recovery & Blowout. Curated wellness retreats are offered for solo travelers, couples, families such as Path to Well-Being Retreat, Peak Pursuits Adventure Retreat for Men and Blissful Bonding Retreat.
The resort provides the perfect backdrop for holistic healing and relaxation. Montevalle Spa & Wellness Resort Montevalle Spa & Wellness Resort, Valle de Guadalupe, Mexico
Montevalle Spa & Wellness Resort empowers individuals through holistic treatments and therapies. Valle De Guadalupe's natural beauty makes it an ideal setting for ultimate serenity and relaxation. Known for its scenic vineyards and tranquil environment, it provides the perfect backdrop for holistic healing and relaxation. Features include: a Meditation Labyrinth designed for mindfulness and stress reduction; Spa offers a range of experiences such as intravenous infusions, holistic therapies and massages; Reflexology Pathway where guests are invited to discover its healing power; Liebre which offers a dining experience focusing on fresh, locally sourced, and organic ingredients; The Quiet Room for yoga and meditation; Private villas surrounded by olive trees and lavender fields.
Programs are designed to enhance mental clarity and reduce stress. John Athimaritis, Six Senses La Sagesse Six Senses La Sagesse, Grenada
Six Senses La Sagesse recently launched a new Digital Detox Program designed to enhance mental clarity, reduce stress, improve sleep quality, boost focus, strengthen real-life connections and promote mindfulness. Details include: Unplugged Meals – Visitors can enjoy relaxed, communal dining experiences without digital distractions. Phones can be secured in Yondr Boxes placed next to the dining table, and conversation cards are provided to encourage meaningful dialogue. Unplugged Experiences – Guests can choose a three-to-seven-night digital detox stay featuring grounding meditation, Yoga Nidra and Alchemy Bar sessions, holistic healing treatments, signature massages, wellness meals and nightly sound healing or storytelling rituals around a bonfire. Forbes The Uber-Rich Are Flocking To This Small Mountain Town By Roger Sands Forbes How To Best Experience The Great American Road Trip By Roger Sands
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics. The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical and clinical studies, including a device clinical study demonstrating excellent performance with 100% of study participants stating they would likely use the BD Libertas™ Wearable Injector if prescribedi,ii. The pharma-sponsored combination product clinical trial represents a significant advancement in accelerating innovation in drug-device combination products that provide greater flexibility for patients, including potential conversion from infused medications that require patients to travel to a hospital or clinic to more convenient patient care in various settings, including self-injection at home. "This trial demonstrates BD's commitment to helping pharma companies by advancing large-volume injection science, ensuring therapies are accessible and patient friendly by offering more efficient and convenient options for biologics," said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. "BD's enhanced testing capabilities acquired through ZebraSci and the proven capabilities of the BD Libertas™ Wearable Injector technology further position BD as an innovative leader in drug delivery." The BD Libertas™ Wearable Injector is an innovative, prefilled, patient ready-to-use drug delivery systemiii designed to enable delivery of complex biologics via subcutaneous injection. The biologics market is expected to grow to more than $670 billioniv by 2030 and for pharmaceutical companies developing these complex drugs, the BD Libertas™ Wearable Injector offers a customizable, patient-centric solution. The BD Libertas™ Wearable Injector: Supports delivery of high-viscosity biologics (up to 50 centipoise), enabling a wide range of subcutaneous therapies Is offered in 2 to 5 mL and 5 to 10 mL configurations providing flexibility for diverse therapeutic requirements Features a fully mechanical, patient ready-to-use design with a simple "peel, stick and click" mechanism, requiring no end-user filling or assemblyiii BD's ongoing validations of fill-finish and final assembly processes with multiple Contract Manufacturing Organizations (CMOs) enable the company to support pharmaceutical partners from development through commercial-scale production. For more information about how BD Libertas™ Wearable Injector is enabling biologic therapy delivery, visit About BD Libertas™ Wearable InjectorBD Libertas™ Wearable Injector is a product in development; some statements are forward looking and are subject to a variety of risks and uncertainties. BD Libertas™ Wearable Injector is a device component intended for drug-device combination products and not subject to FDA 510(k) clearance or separate EU CE mark certification. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. Contacts: Media: Investors: Fallon McLoughlin Adam Reiffe BD Corporate Communications BD Investor Relations 201.258.0361 201.847.6927 i Early feasibility clinical study of investigational BD Libertas™ Wearable Injector (WI) evaluated 5ml, non- Newtonian ~8cP subcutaneous placebo injections in 52 healthy adult subjects for functionality, tissue effects, subject tolerability (100mm Visual Analog Scale (VAS)) and acceptability (questionnaires with 5-point Likert or yes /no responses). Tissue effects were measured from WI removal post-injection through 24 hours with calipers (wheals) or graded on a 5-point scale (erythema, bleeding) from 0-none to 4-severe, significant, respectively. Where tissue effects were observed, the majority (>50%) were resolved within 60 minutes and all within 24 hours. Subject pain (100mm VAS) peaked mid-injection (mean 9.1mm, SD 13.4) and rapidly resolved within 30 minutes (mean 0 .4mm, SD 2.6). Subjects found acceptable (Likert agree + strongly agree or yes responses) their peak pain (≥90.2%), injection site appearance (≥92.2% ).ii Woodley, W. D. et al. Clinical Evaluation of an Investigational 5ml Wearable Injector in Healthy Human Subjects. Clin Transl Sci. 2021 May;14(3):859-869. Pharma filled and assemblediv Mordor Intelligence (2025). Biologics Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030). View original content to download multimedia: SOURCE BD (Becton, Dickinson and Company) Sign in to access your portfolio
Yahoo
12 minutes ago
- Yahoo
U.S. Physical Therapy, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call Dates
HOUSTON, July 23, 2025--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and six months ended June 30, 2025, on Wednesday, August 6, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, August 7, 2025. Conference Call Date: Thursday, August 7, 2025 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number: (800) 343-4136 Primary or (203) 518-9843 Alternate Conference ID: USPHQ225 (In order to join this conference call,you will be required to provide the Conference ID listed above) To participate, please call in 15 minutes prior to start time. To listen to the live call, please go to and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until November 5, 2025 at USPH's website. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 768 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention business which provides onsite services for clients' employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. More information about U.S. Physical Therapy, Inc. is available at The information included on that website is not incorporated into this press release. View source version on Contacts U.S. Physical Therapy, Hendrickson, Chief Financial OfficerEmail: Chendrickson@ Chris Reading, Chief Executive Officer(713) 297-7000 Three Part AdvisorsJoe Noyons(817) 778-8424
Yahoo
12 minutes ago
- Yahoo
The president vows to slash medication cost to an unachievable degree.
President Donald Trump has promised to reduce American drug prices by mathematically impossible figures of up to '1400 percent.' Speaking during a White House event attended by Republican members of Congress and his Cabinet, Trump said he would tackle the long-running issue of high medication costs in the U.S. But Trump did not set any achievable targets for that aim, instead outlining a range of percentages which would yield negative prices, meaning drug companies would have to pay people to take their medications.
